Loading clinical trials...
Loading clinical trials...
Conditions
Locations
13
Russia
Novartis Investigative Site
Cheboksary, Russia
Novartis Investigative Site
Grozny, Russia
Novartis Investigative Site
Kemerovo, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Moscow, Russia
Novartis Investigative Site
Novosibirsk, Russia
Start Date
September 30, 2025
Primary Completion Date
September 30, 2027
Completion Date
September 30, 2027
Last Updated
April 16, 2026
NCT05168462
NCT04528511
NCT07052799
NCT03854071
NCT06113510
NCT06744322
Novartis Pharmaceuticals
CONTACT
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions